Evidence map›Paper›PMID 36384478›Full record

ArticleBMC geriatrics2022

CELPI: trial protocol for a randomised controlled trial of a Carer End of Life Planning Intervention in people dying with dementia.

G Arendts, L Chenoweth, B J Hayes, E Campbell, M Agar, C Etherton-Beer, K Spilsbury, K Howard, G Braitberg, M Cubitt and 11 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC geriatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

G ArendtsDiscipline of Emergency Medicine, Medical School, University of Western Australia, Perth, WA, Australia. glenn.arendts@uwa.edu.au.ORCID 0000-0001-7830-7756
L ChenowethCentre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
B J HayesNorthern Health Epping, Victoria, Australia.
E CampbellGeriatric Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
M AgarCentre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation, University of Technology, Sydney, Australia.
C Etherton-BeerWA Centre for Health and Ageing, University of Western Australia, Perth, WA, Australia.
K SpilsburyUniversity of Notre Dame, Fremantle, WA, Australia.
K HowardSchool of Public Health, University of Sydney, Camperdown, NSW, Australia.
G BraitbergEmergency Medicine, Austin Health, Victoria, Australia.
M CubittEmergency Medicine, The Royal Melbourne Hospital, Victoria, Australia.
C SheehanPalliative Care Medicine, St George Hospital, NSW, Kogarah, Australia.
L MagannPalliative Care Medicine, St George Hospital, NSW, Kogarah, Australia.
T SudharshanEmergency Medicine, Liverpool Hospital, Sydney, Australia.
L M SchnitkerSchool of Nursing, Queensland University of Technology, Brisbane, Australia.
J PearceFiona Stanley Hospital, Murdoch, WA, Australia.
I GilmoreCentre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation, University of Technology, Sydney, Australia.
N CerraNorthern Health Epping, Victoria, Australia.
J duPreezDiscipline of Emergency Medicine, Medical School, University of Western Australia, Perth, WA, Australia.
R JaworskiDiscipline of Emergency Medicine, Medical School, University of Western Australia, Perth, WA, Australia.
S-C SohDiscipline of Emergency Medicine, Medical School, University of Western Australia, Perth, WA, Australia.
A CelenzaDiscipline of Emergency Medicine, Medical School, University of Western Australia, Perth, WA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDementia is a leading cause of death in developed nations. Despite an often distressing and symptom laden end of life, there are systematic barriers to accessing palliative care in older people dying of dementia. Evidence exists that 70% of people living with severe dementia attend an emergency department (ED) in their last year of life. The aim of this trial is to test whether a Carer End of Life Planning Intervention (CELPI), co-designed by consumers, clinicians and content specialists, improves access to end of life care for older people with severe dementia, using an ED visit as a catalyst for recognising unmet needs and specialist palliative care referral where indicated.

methodsA randomised controlled trial (RCT) enrolling at six EDs across three states in Australia will be conducted, enrolling four hundred and forty dyads comprising a person with severe dementia aged ≥ 65 years, and their primary carer. Participants will be randomly allocated to CELPI or the control group. CELPI incorporates a structured carer needs assessment and referral to specialist palliative care services where indicated by patient symptom burden and needs assessment. The primary outcome measure is death of the person with dementia in the carer-nominated preferred location. Secondary outcomes include carer reported quality of life of the person dying of dementia, hospital bed day occupancy in the last 12 months of life, and carer stress. An economic evaluation from the perspective of a health funder will be conducted. DISCUSSION: CELPI seeks to support carers and provide optimal end of life care for the person dying of dementia. This trial will provide high level evidence as to the clinical and cost effectiveness of this intervention.

trial registrationACTRN12622000611729 registered 22/04/2022.

Indexed as

CaregiversDementiaAgedDeathHumansPalliative CareQuality of LifeRandomized Controlled Trials as TopicDementiaEmergency medicinePalliative carePerson-centred careRandomised controlled trial

Identifiers

PMID36384478
PMCPMC9670369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.